You have 9 free searches left this month | for more free features.

hyporesponsive

Showing 1 - 25 of 30

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Anemia, Dialysis-Dependent Chronic Kidney Disease Trial in United States (vadadustat, epoetin alfa)

Terminated
  • Anemia
  • Dialysis-Dependent Chronic Kidney Disease
  • Bakersfield, California
  • +17 more
Feb 2, 2021

Chronic Kidney Disease Hyporesponsive Anemia to Erythropoiesis

Completed
  • Renal Anemia
  • Chronic Kidney Disease
    • Niigata, Japan
      Niigata University Graduate School of Medicine
    Jun 17, 2020

    Intracranial Aneurysm Trial in Gyeonggi-do (Prasugrel group, Clopidogrel group)

    Recruiting
    • Intracranial Aneurysm
    • Prasugrel group
    • Clopidogrel group
    • Gyeonggi-do, Yongin-si, Korea, Republic of
      Yongin Severance hospital, Yonsei university college of medicine
    Jul 13, 2022

    AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Mixed Phenotype Acute Leukemia Trial in Palo Alto (T-allo10)

    Recruiting
    • AML - Acute Myeloid Leukemia
    • +5 more
    • T-allo10
    • Palo Alto, California
      Lucile Packard Children's Hospital
    Feb 2, 2022

    End Stage Renal Disease, Anemia Trial in United States (Roxadustat, Epoetin Alfa, Placebo)

    Completed
    • End Stage Renal Disease
    • Anemia
    • Tempe, Arizona
    • +24 more
    Dec 14, 2021

    IBD Trial in Worcester (The IBD-AID)

    Completed
    • Inflammatory Bowel Diseases
    • The IBD-AID
    • Worcester, Massachusetts
      University of Massachusetts Medical School
    Feb 11, 2021

    Diseases Specified as Adverse Events of Special Interest, of

    Active, not recruiting
    • Malaria
    • Malaria Vaccines
    • Blood collection
    • Ouagadougou, Burkina Faso
    • +4 more
    Oct 18, 2021

    Pantothenate Kinase-Associated Neurodegeneration Trial in Worldwide (Deferiprone oral solution)

    Completed
    • Pantothenate Kinase-Associated Neurodegeneration
    • Deferiprone oral solution
    • Oakland, California
    • +3 more
    Aug 12, 2020

    Anemia Trial in United States (GSK1278863, Placebo)

    Terminated
    • Anemia
    • Azusa, California
    • +18 more
    May 22, 2017

    Leukemia, MDS Trial in United States (biological, drug, procedure, radiation)

    Completed
    • Leukemia
    • Myelodysplastic Syndromes
    • anti-thymocyte globulin
    • +7 more
    • Los Angeles, California
    • +5 more
    Jul 1, 2019

    Infections, Streptococcal, Streptococcus Pneumoniae Trial in Helsinki (Pneumococcal conjugate vaccine GSK1024850A, GSK

    Completed
    • Infections, Streptococcal
    • Streptococcus Pneumoniae
    • Pneumococcal conjugate vaccine GSK1024850A
    • +2 more
    • Helsinki, Finland
      GSK Investigational Site
    Nov 20, 2020

    Respiratory Syncytial Virus Infections Trial in Worldwide (Suptavumab 30 mg/kg, Placebo Matched to Suptavumab, Suptavumab 30

    Completed
    • Respiratory Syncytial Virus Infections
    • Suptavumab 30 mg/kg
    • +3 more
    • Birmingham, Alabama
    • +204 more
    Oct 8, 2018

    Infections, Streptococcal Trial in Worldwide (Pneumococcal conjugate vaccine GSK2830929A, Pneumococcal conjugate vaccine

    Completed
    • Infections, Streptococcal
    • Pneumococcal conjugate vaccine GSK2830929A
    • +4 more
    • Benesov, Czechia
    • +41 more
    Jul 2, 2019

    Infections, Streptococcal Trial in Worldwide (Pneumococcal vaccine GSK 2189242A (LD formulation 1), Pneumococcal vaccine GSK

    Completed
    • Infections, Streptococcal
    • Pneumococcal vaccine GSK 2189242A (LD formulation 1)
    • +4 more
    • Benesov, Czechia
    • +23 more
    May 17, 2019

    Acute Alcoholic Hepatitis Trial in Worldwide (ELAD treatment, Standard of care (Control))

    Completed
    • Acute Alcoholic Hepatitis
    • ELAD treatment
    • Standard of care (Control)
    • Phoenix, Arizona
    • +44 more
    Jan 22, 2019

    Acute Coronary Syndrome Trial in Lancaster (Placebo, St. Johns Wort)

    Withdrawn
    • Acute Coronary Syndrome
    • Placebo
    • St. Johns Wort
    • Lancaster, Pennsylvania
      Lancaster General Hospital
    Oct 3, 2017

    Anemia, End Stage Renal Disease Trial in Germany, Italy, United Kingdom (Lexaptepid pegol (NOX-H94), Placebo)

    Completed
    • Anemia
    • End Stage Renal Disease
    • Lexaptepid pegol (NOX-H94)
    • Placebo
    • Düsseldorf, Germany
    • +9 more
    Nov 23, 2015

    Influenza, HIV Trial in Canada (Fluviral)

    Completed
    • Influenza
    • HIV
    • Fluviral
    • Calgary, Alberta, Canada
    • +12 more
    Apr 26, 2017

    Neisseria Meningitidis, Haemophilus Influenzae Type b Trial in North Adelaide, Carlton, Perth (MenHibrix (Hib-MenCY-TT),

    Completed
    • Neisseria Meningitidis
    • Haemophilus Influenzae Type b
    • MenHibrix (Hib-MenCY-TT)
    • +7 more
    • North Adelaide, South Australia, Australia
    • +2 more
    May 24, 2018

    ENsure Clinical Equivalence

    Completed
    • Acute Coronary Syndrome
    • +5 more
      • Ioannina, Epirus, Greece
        Atherothrombosis Research Centre / Laboratory of Biochemistry, U
      Dec 15, 2015

      Sepsis Trial in Nijmegen (BCG vaccine, Lipopolysaccharide (LPS) E. Coli 1 ng/kg intravenously)

      Completed
      • Sepsis
      • BCG vaccine
      • Lipopolysaccharide (LPS) E. Coli 1 ng/kg intravenously
      • Nijmegen, Netherlands
        Radboud University Medical Centre, Intensive Care
      May 12, 2015

      Diabetes Trial in Padova (Mozobil)

      Completed
      • Diabetes
      • Padova, Italy
        Policlinico Universitario, Azienda Ospedaliera di Padova
      Oct 22, 2014

      Meningococcal Infections Trial in Worldwide (rMenB+OMV NZ, combined diphtheria,tetanus,pertussis+polio+Hepatitis B+Haemophilus

      Completed
      • Meningococcal Infections
      • rMenB+OMV NZ
      • +2 more
      • Edegem, Antwerpen, Belgium
      • +59 more
      Mar 17, 2015

      Diphtheria, Tetanus, Pertussis Trial in Mexico DF, Lima (DTaP-IPV-HB-PRP~T, Tritanrix-HepB/Hib)

      Completed
      • Diphtheria
      • +4 more
      • DTaP-IPV-HB-PRP~T
      • Tritanrix-HepB/Hib
      • Mexico DF, Mexico
      • +1 more
      Apr 2, 2014

      Cat Allergy Trial in Baltimore (Omalizumab, Placebo)

      Completed
      • Cat Allergy
      • Baltimore, Maryland
        Johns Hopkins Asthma and Allergy Center
      Feb 24, 2014